Posted: Thursday, October 24, 2024
Kara N. Maxwell, MD, PhD, of the University of Pennsylvania, explores what she and her colleagues have learned about the importance of oncologists being vigilant about offering genetic testing to men. By identifying more male carriers of BRCA1/2 alterations, there will be more opportunities for early detection of breast cancer as well as targeted risk management for these male patients.